Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Advocacy (policy advocacy, lobbying)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Roles and responsibilities
Clinical study phase I